Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 75.50%
March 31, 2026 75.75%
December 31, 2025 77.62%
September 30, 2025 75.10%
June 30, 2025 73.73%
March 31, 2025 72.98%
December 31, 2024 74.47%
September 30, 2024 74.09%
June 30, 2024 73.03%
March 31, 2024 70.06%
December 31, 2023 71.31%
September 30, 2023 70.02%
June 30, 2023 68.43%
March 31, 2023 68.23%
December 31, 2022 69.62%
September 30, 2022 70.71%
June 30, 2022 71.39%
March 31, 2022 69.23%
December 31, 2021 71.87%
September 30, 2021 70.05%
June 30, 2021 70.91%
March 31, 2021 70.68%
December 31, 2020 70.65%
September 30, 2020 71.24%
June 30, 2020 70.93%
Date Value
March 31, 2020 71.15%
December 31, 2019 72.03%
September 30, 2019 71.30%
June 30, 2019 69.70%
March 31, 2019 69.80%
December 31, 2018 68.93%
September 30, 2018 72.08%
June 30, 2018 71.85%
March 31, 2018 72.78%
December 31, 2017 74.69%
September 30, 2017 73.38%
June 30, 2017 73.22%
March 31, 2017 71.67%
December 31, 2016 73.58%
September 30, 2016 72.25%
June 30, 2016 73.01%
March 31, 2016 75.11%
December 31, 2015 76.04%
September 30, 2015 73.45%
June 30, 2015 70.42%
March 31, 2015 70.64%
December 31, 2014 75.53%
September 30, 2014 72.18%
June 30, 2014 72.98%
March 31, 2014 70.26%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Treace Medical Concepts, Inc. 78.47%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%

Gross Profit Margin (Quarterly) Related Metrics